DEFLAZACORT ORAL SUSPENSION
Generic: DEFLAZACORT ORAL
Sun Pharmaceutical IndustriesManufacturer
ORALRoute
DEFLAZACORTActive Substance
2026-01-27Original Approval
DEFLAZACORT ORAL SUSPENSION is FDA application ANDA219930, sponsored by SUN PHARM INDS INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
194 reports
2
PAIN
186 reports
3
ARTHRALGIA
168 reports
4
OFF LABEL USE
152 reports
5
PYREXIA
142 reports
6
PAIN IN EXTREMITY
127 reports
7
MALAISE
125 reports
8
RHEUMATOID ARTHRITIS
125 reports
9
VOMITING
123 reports
10
HEADACHE
115 reports